Association of circulating visfatin level and metabolic fatty liver disease: An updated meta-analysis and systematic review.

ABSTRACT:

Background

The rate of incidence of metabolic dysfunction-related fatty liver disease (MAFLD) has rapidly increased globally in recent years, but early diagnosis is still a challenge. The purpose of this systematic review and meta-analysis is to identify visfatin for early diagnosis of MAFLD.

Methods

We strictly adhered to the relevant requirements of Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The systematic search was conducted in 7 sources (PubMed, Embase, Cochrane Library, CNKI, Wanfang, CBM, and ClinicalTrials.gov) until February 2024. The meta-analysis was performed using Stata 12. Outcomes were expressed in the form of standardized mean difference (SMD) and 95% confidence interval and were analyzed using meta-analysis.

Results

SUBMITTER: Chen S 

PROVIDER: S-EPMC11404888 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature